A Phase II Window Study of Front-line Axitinib Followed by Axitinib and Radiation for Elderly Patients With Glioblastoma Multiforme (GBM).
Phase of Trial: Phase II
Latest Information Update: 21 Sep 2017
At a glance
- Drugs Axitinib (Primary)
- Indications Glioblastoma
- Focus Therapeutic Use
- 18 Aug 2017 Status changed from recruiting to discontinued due to transfer of study sponsor.
- 18 Jan 2012 New trial record